BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3084179)

  • 1. Interferon and growth factor activity for human lung fibroblasts. Release from bronchoalveolar cells from patients with active sarcoidosis.
    Moseley PL; Hemken C; Monick M; Nugent K; Hunninghake GW
    Chest; 1986 May; 89(5):657-62. PubMed ID: 3084179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
    Robinson BW; McLemore TL; Crystal RG
    J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the immune response in sarcoidosis.
    Hunninghake GW; Fulmer JD; Young RC; Gadek JE; Crystal RG
    Am Rev Respir Dis; 1979 Jul; 120(1):49-57. PubMed ID: 313729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage.
    Tazi A; Nioche S; Chastre J; SmiƩjan JM; Hance AJ
    Am J Respir Cell Mol Biol; 1991 Feb; 4(2):140-7. PubMed ID: 1703767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased pulmonary gamma interferon production in asbestosis.
    Robinson BW; Rose AH; Hayes A; Musk AW
    Am Rev Respir Dis; 1988 Aug; 138(2):278-83. PubMed ID: 3143284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic abnormalities in sarcoidosis.
    Daniele RP; Dauber JH; Rossman MD
    Ann Intern Med; 1980 Mar; 92(3):406-16. PubMed ID: 6986831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The response of alveolar lymphocytes induced by Propionibacterium acnes in pulmonary sarcoidosis: correlation with clinical studies, pulmonary function studies and bronchoalveolar lavage].
    Nakata Y; Kataoka M; Ejiri T; Mori Y; Hioka T; Maeda T; Hosoya S; Ohnoshi T; Kimura I
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jul; 27(7):837-41. PubMed ID: 2810973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.
    Prior C; Haslam PL
    Clin Exp Immunol; 1992 May; 88(2):280-7. PubMed ID: 1572093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bronchoalveolar immunoglobulins in sarcoidosis].
    Bauer W; Gorny MK; Morell A; Baumann HR
    Schweiz Med Wochenschr; 1985 Jan; 115(3):103-5. PubMed ID: 3871964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.
    Lem VM; Lipscomb MF; Weissler JC; Nunez G; Ball EJ; Stastny P; Toews GB
    J Immunol; 1985 Sep; 135(3):1766-71. PubMed ID: 3874905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking and bronchoalveolar T cell populations in sarcoidosis.
    Lawrence EC; Fox TB; Teague RB; Bloom K; Wilson RK
    Ann N Y Acad Sci; 1986; 465():657-64. PubMed ID: 2942080
    [No Abstract]   [Full Text] [Related]  

  • 12. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases.
    Nagai S; Aung H; Takeuchi M; Kusume K; Izumi T
    Chest; 1991 Mar; 99(3):674-80. PubMed ID: 1995225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets.
    Greening AP; Nunn P; Dobson N; Rudolf M; Rees AD
    Thorax; 1985 Apr; 40(4):278-83. PubMed ID: 3875160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis.
    Hunninghake GW; Bedell GN; Zavala DC; Monick M; Brady M
    Am Rev Respir Dis; 1983 Oct; 128(4):634-8. PubMed ID: 6226225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchoalveolar T lymphocytes and pulmonary sarcoidosis.
    Hunninghake GW
    Clin Rev Allergy; 1985 May; 3(2):227-34. PubMed ID: 3886118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of alveolar macrophage- and lung T cell-derived mediators in pulmonary sarcoidosis.
    Hunninghake GW
    Ann N Y Acad Sci; 1986; 465():82-90. PubMed ID: 2425678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.
    Hunninghake GW
    Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interleukin 1 secretion from alveolar macrophages in pulmonary sarcoidosis].
    Barth J; Kreipe H; Radzun HJ; Petermann W
    Pneumologie; 1990 Feb; 44 Suppl 1():215-6. PubMed ID: 2367368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary sarcoidosis: excess of helper T lymphocytes and T cell subset imbalance at sites of disease activity.
    Rossi GA; Sacco O; Cosulich E; Damiani G; Corte G; Bargellesi A; Ravazzoni C
    Thorax; 1984 Feb; 39(2):143-9. PubMed ID: 6230751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of helper T-lymphocytes in bronchoalveolar lavage for the evaluation of the activity of pulmonary sarcoidosis].
    Costabel U; Bross KJ; Fischer J; Guzman J; Matthys H
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():574-7. PubMed ID: 6227882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.